Erin Collins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erin Collins has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Julian Little
School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Canada
7 shared publications Corey Arnold
Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine University of Ottawa Ottawa Ontario Canada
5 shared publications- Marc-André Langlois
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
5 shared publications Yannick Galipeau
Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine University of Ottawa Ottawa Ontario Canada
5 shared publicationsMichaeline McGuinty
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
4 shared publicationsRaphael Saginur
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
4 shared publications
Latest Publications
- Open Access
- 9 December 2025
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (1) , 100310
The impact of moral injury-related content on reasoning and its neural correlates: Data from the Canadian Armed Forces (CAF)
- 9 December 2025
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (1) , 100310
Open AccessThe impact of moral injury-related content on reasoning and its neural correlates: Data from the Canadian Armed Forces (CAF)
- Open Access
Household income among families with autistic children and youths in Canada: a cross-sectional matched cohort study
Objective: Within the Canadian context, we sought to examine the relationship between households with autistic children/youths and household income. Design: We used data from the 2019 Canadian Health Survey on Children and Youth (CHSCY) to analyse households with a child/youth aged 1–17. Propensity-score matching was used to pair records for children/youths with a reported autism diagnosis to those without. We used linear regression for continuous outcomes (eg, total household income) and Poisson regression for binary outcomes (eg, low household income). All analyses were adjusted for the correlation between matched pairs. Primary outcome measure: Total annual income of all household members. Secondary outcome measures: Low household income; single-parent or single-income status; and whether at least one parent was not working or absent from work during the past week. Results: Among a total of 39 951 CHSCY records, we identified a cohort of 815 autistic children/youths. The characteristics of the matched cohort were well-balanced. Households with an autistic child/youth had a mean annual household income that was lower (mean difference: $C16 489; 95% CI $C6384 to $C27 149) compared with matched households without an autistic child/youth. Households with an autistic child/youth were also 26% more likely to be classified as having a low household income (Relative risk (RR) 1.26; 95% CI 1.17 to 1.35) and 20% more likely to rely on a single income (RR 1.20; 95% CI 1.10 to 1.33) compared with households without an autistic child/youth. Conclusions: Compared with households without an autistic child/youth, those with an autistic child/youth often face more economic challenges, including lower household income and greater risk of food insecurity. Households with an autistic child/youth are more likely to rely on a single income.
Open AccessHousehold income among families with autistic children and youths in Canada: a cross-sectional matched cohort study
Objective: Within the Canadian context, we sought to examine the relationship between households with autistic children/youths and household income. Design: We used data from the 2019 Canadian Health Survey on Children and Youth (CHSCY) to analyse households with a child/youth aged 1–17. Propensity-score matching was used to pair records for children/youths with a reported autism diagnosis to those without. We used linear regression for continuous outcomes (eg, total household income) and Poisson regression for binary outcomes (eg, low household income). All analyses were adjusted for the correlation between matched pairs. Primary outcome measure: Total annual income of all household members. Secondary outcome measures: Low household income; single-parent or single-income status; and whether at least one parent was not working or absent from work during the past week. Results: Among a total of 39 951 CHSCY records, we identified a cohort of 815 autistic children/youths. The characteristics of the matched cohort were well-balanced. Households with an autistic child/youth had a mean annual household income that was lower (mean difference: $C16 489; 95% CI $C6384 to $C27 149) compared with matched households without an autistic child/youth. Households with an autistic child/youth were also 26% more likely to be classified as having a low household income (Relative risk (RR) 1.26; 95% CI 1.17 to 1.35) and 20% more likely to rely on a single income (RR 1.20; 95% CI 1.10 to 1.33) compared with households without an autistic child/youth. Conclusions: Compared with households without an autistic child/youth, those with an autistic child/youth often face more economic challenges, including lower household income and greater risk of food insecurity. Households with an autistic child/youth are more likely to rely on a single income.
- Open Access
Navigating transition: A mixed methods study protocol for understanding chronic pain, resilience, and well-being among Canadian Armed Forces Veterans, families, and service providers
Introduction Transitioning from military to civilian life is often challenging for Canadian Armed Forces (CAF) Veterans, and chronic pain further complicates reintegration and wellbeing. Family members and service providers play critical but understudied roles in this process. Methods This mixed-methods study combines secondary analysis of the previous dataset with new qualitative interviews. Quantitative analyses will describe characteristics of Veterans with chronic pain and assess associations between pain severity and transition outcomes using regression models. Qualitative interviews with Veterans (n=10), family members (n=10), and service providers (n=10) will explore pain management, barriers and facilitators to care, and resilience strategies, analyzed using both deductive (framework-guided) and inductive thematic approaches. Results Findings will identify correlates of chronic pain and transition outcomes, as well as systemic gaps and resilience-enabling supports across the transition continuum. Discussion This study is the first in Canada to examine chronic pain in Veterans’ transition through a multi-system lens inclusive of family and provider perspectives. Grounded in resilience frameworks, the design addresses individual, relational, and structural influences on post-service adjustment. Anticipated findings will inform targeted interventions, caregiver supports, and provider education to strengthen resilience and improve care coordination for Veterans with chronic pain.
Open AccessNavigating transition: A mixed methods study protocol for understanding chronic pain, resilience, and well-being among Canadian Armed Forces Veterans, families, and service providers
Introduction Transitioning from military to civilian life is often challenging for Canadian Armed Forces (CAF) Veterans, and chronic pain further complicates reintegration and wellbeing. Family members and service providers play critical but understudied roles in this process. Methods This mixed-methods study combines secondary analysis of the previous dataset with new qualitative interviews. Quantitative analyses will describe characteristics of Veterans with chronic pain and assess associations between pain severity and transition outcomes using regression models. Qualitative interviews with Veterans (n=10), family members (n=10), and service providers (n=10) will explore pain management, barriers and facilitators to care, and resilience strategies, analyzed using both deductive (framework-guided) and inductive thematic approaches. Results Findings will identify correlates of chronic pain and transition outcomes, as well as systemic gaps and resilience-enabling supports across the transition continuum. Discussion This study is the first in Canada to examine chronic pain in Veterans’ transition through a multi-system lens inclusive of family and provider perspectives. Grounded in resilience frameworks, the design addresses individual, relational, and structural influences on post-service adjustment. Anticipated findings will inform targeted interventions, caregiver supports, and provider education to strengthen resilience and improve care coordination for Veterans with chronic pain.
- Open Access
Prevalence of autism among adults in Canada: results from a simulation modelling study
Objective To estimate the prevalence of autism among adults living in Canada. Design A Monte Carlo simulation modelling approach was employed. Input parameters included adult population estimates and mortality rates; autism population all-cause mortality risk ratios; and autism prevalence estimates derived from child and youth data due to the lack of adult data. This approach was executed through 10 000 simulations, with each iteration generating a distinct data scenario. Prevalence estimates were reported as the mean with the 2.5th and 97.5th percentiles, corresponding to a 95% simulation interval (SI). Setting Where possible, Canadian data sources were used, including the 2019 Canadian Health Survey on Children and Youth and Statistics Canada mortality rates and population estimates. Primary outcome measure National prevalence estimates of autistic adults living in private dwellings in Canada, with variations in prevalence by sex at birth and province/territory considered. Results The findings suggest the prevalence of autism among adults in Canada to be 1.8% (95% SI 1.6%, 2.0%). National prevalence estimates by sex at birth were 0.7% (95% SI 0.6%, 0.9%) for females and 2.9% (95% SI 2.6%, 3.2%) for males. Provincial/territorial estimates ranged from 0.7% in Saskatchewan (95% SI 0.3%, 1.3%) to 3.6% in New Brunswick (95% SI 2.4%, 5.1%). Conclusions The limited availability of data on autistic adults constrains our ability to fully understand and address their unique needs. In this study, autism prevalence was estimated based on diagnosed cases, which excludes individuals without a formal diagnosis. Additionally, other factors such as data availability and methodological assumptions may influence the modelling of prevalence estimates. As a result, our findings should be interpreted within the context of these limitations. Nevertheless, this study provides a valuable reference point for understanding autism prevalence among adults in Canada.
Open AccessPrevalence of autism among adults in Canada: results from a simulation modelling study
Objective To estimate the prevalence of autism among adults living in Canada. Design A Monte Carlo simulation modelling approach was employed. Input parameters included adult population estimates and mortality rates; autism population all-cause mortality risk ratios; and autism prevalence estimates derived from child and youth data due to the lack of adult data. This approach was executed through 10 000 simulations, with each iteration generating a distinct data scenario. Prevalence estimates were reported as the mean with the 2.5th and 97.5th percentiles, corresponding to a 95% simulation interval (SI). Setting Where possible, Canadian data sources were used, including the 2019 Canadian Health Survey on Children and Youth and Statistics Canada mortality rates and population estimates. Primary outcome measure National prevalence estimates of autistic adults living in private dwellings in Canada, with variations in prevalence by sex at birth and province/territory considered. Results The findings suggest the prevalence of autism among adults in Canada to be 1.8% (95% SI 1.6%, 2.0%). National prevalence estimates by sex at birth were 0.7% (95% SI 0.6%, 0.9%) for females and 2.9% (95% SI 2.6%, 3.2%) for males. Provincial/territorial estimates ranged from 0.7% in Saskatchewan (95% SI 0.3%, 1.3%) to 3.6% in New Brunswick (95% SI 2.4%, 5.1%). Conclusions The limited availability of data on autistic adults constrains our ability to fully understand and address their unique needs. In this study, autism prevalence was estimated based on diagnosed cases, which excludes individuals without a formal diagnosis. Additionally, other factors such as data availability and methodological assumptions may influence the modelling of prevalence estimates. As a result, our findings should be interpreted within the context of these limitations. Nevertheless, this study provides a valuable reference point for understanding autism prevalence among adults in Canada.
- Open Access
Study protocol for a descriptive analysis of non-invasive prenatal testing uptake and performance in singleton and twin pregnancies using Ontario birth registry data
Introduction Despite the availability of funded first-tier non-invasive prenatal testing (NIPT) for twin pregnancies in Ontario, Canada, research gaps persist regarding the feasibility and effectiveness of NIPT in this demographic. This protocol documents our planned comprehensive overview of twin data from the large Ontario provincial registry and evaluates the performance of NIPT among singleton and twin pregnancies. Methods and analysis We will conduct a descriptive study using routinely collected data housed in the Better Outcomes Registry & Network Ontario. The study population will include all singleton and twin pregnancies with an estimated date of delivery between 1 September 2016 and 31 March 2023. We will compare patient characteristics, NIPT uptake and test performance metrics (including sensitivity, specificity, positive predictive value and negative predictive value) between singleton and twin pregnancies. Subgroup analyses will be conducted, including assessment by the mode of conception, trimester of initial screening, age of the pregnant individual and eligibility for publicly funded first-tier NIPT. Ethics and dissemination This study has received approval from the Research Ethics Boards of the Children’s Hospital of Eastern Ontario (24/01PE) and the University of Ottawa (H-04-24-10309). Results will be disseminated through scientific conferences and publication in a peer-reviewed journal. By making our protocol and findings publicly available, we aim to establish a foundational reference for future investigations in Ontario. Additionally, we seek to support the design and implementation of further studies on NIPT in twin pregnancies in Canada and elsewhere.
Open AccessStudy protocol for a descriptive analysis of non-invasive prenatal testing uptake and performance in singleton and twin pregnancies using Ontario birth registry data
Introduction Despite the availability of funded first-tier non-invasive prenatal testing (NIPT) for twin pregnancies in Ontario, Canada, research gaps persist regarding the feasibility and effectiveness of NIPT in this demographic. This protocol documents our planned comprehensive overview of twin data from the large Ontario provincial registry and evaluates the performance of NIPT among singleton and twin pregnancies. Methods and analysis We will conduct a descriptive study using routinely collected data housed in the Better Outcomes Registry & Network Ontario. The study population will include all singleton and twin pregnancies with an estimated date of delivery between 1 September 2016 and 31 March 2023. We will compare patient characteristics, NIPT uptake and test performance metrics (including sensitivity, specificity, positive predictive value and negative predictive value) between singleton and twin pregnancies. Subgroup analyses will be conducted, including assessment by the mode of conception, trimester of initial screening, age of the pregnant individual and eligibility for publicly funded first-tier NIPT. Ethics and dissemination This study has received approval from the Research Ethics Boards of the Children’s Hospital of Eastern Ontario (24/01PE) and the University of Ottawa (H-04-24-10309). Results will be disseminated through scientific conferences and publication in a peer-reviewed journal. By making our protocol and findings publicly available, we aim to establish a foundational reference for future investigations in Ontario. Additionally, we seek to support the design and implementation of further studies on NIPT in twin pregnancies in Canada and elsewhere.
- 28 April 2025
- Published by Wiley in Journal of Traumatic Stress
- Vol. 38 (4) , 720-730
Problematic anger in a treatment‐seeking Canadian veteran population: Prevalence, assessment, and treatment implications
Anger is a natural, adaptive emotion that is culturally accepted in military settings. Problematic anger (i.e., intense anger paired with significant distress and functional impairment linked to) is gaining attention in military and veteran populations. This study examined problematic anger in 882 Canadian Armed Forces personnel and veterans referred to a specialized mental health clinic. Intake assessments included measures of anger, psychological conditions, and military and demographic variables. Approximately 63% of participants reported problematic anger. Respondents who endorsed problematic anger had higher rates of posttraumatic stress disorder (PTSD) symptom severity, d = 1.06; depression, d = 0.82; anxiety symptom frequency, d = 0.94; and harmful drinking, d = 0.36, ps < .001, compared to those who did not. Sequential linear regression analyses demonstrated that PTSD symptom severity, Badjusted = 0.18, 95% CI [0.16, 0.20], R2 = .37, and anxiety symptom frequency, Badjusted = 0.55, 95% CI [0.49, 0.61], R2 = .33, accounted for the largest proportion of the variance in problematic anger symptom severity. This is the first study to report on problematic anger in a Canadian military/veteran context, and the results suggest that almost two thirds of veterans endorsed problematic anger, which is higher than previously reported prevalence rates. This study is a starting point for better understanding risk and vulnerability factors for problematic anger among Canadian military personnel and veterans and clarifying the associations among problematic anger, PTSD, and anxiety symptoms. Implementing standardized screening for problematic anger may improve diagnostic precision, treatment planning, and outcomes.
- 28 April 2025
- Published by Wiley in Journal of Traumatic Stress
- Vol. 38 (4) , 720-730
Problematic anger in a treatment‐seeking Canadian veteran population: Prevalence, assessment, and treatment implications
Anger is a natural, adaptive emotion that is culturally accepted in military settings. Problematic anger (i.e., intense anger paired with significant distress and functional impairment linked to) is gaining attention in military and veteran populations. This study examined problematic anger in 882 Canadian Armed Forces personnel and veterans referred to a specialized mental health clinic. Intake assessments included measures of anger, psychological conditions, and military and demographic variables. Approximately 63% of participants reported problematic anger. Respondents who endorsed problematic anger had higher rates of posttraumatic stress disorder (PTSD) symptom severity, d = 1.06; depression, d = 0.82; anxiety symptom frequency, d = 0.94; and harmful drinking, d = 0.36, ps < .001, compared to those who did not. Sequential linear regression analyses demonstrated that PTSD symptom severity, Badjusted = 0.18, 95% CI [0.16, 0.20], R2 = .37, and anxiety symptom frequency, Badjusted = 0.55, 95% CI [0.49, 0.61], R2 = .33, accounted for the largest proportion of the variance in problematic anger symptom severity. This is the first study to report on problematic anger in a Canadian military/veteran context, and the results suggest that almost two thirds of veterans endorsed problematic anger, which is higher than previously reported prevalence rates. This study is a starting point for better understanding risk and vulnerability factors for problematic anger among Canadian military personnel and veterans and clarifying the associations among problematic anger, PTSD, and anxiety symptoms. Implementing standardized screening for problematic anger may improve diagnostic precision, treatment planning, and outcomes.
- Open Access
- 14 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (4) , e70390
Autoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection
Clinical outcomes resulting from SARS‐CoV‐2 infection vary widely, ranging from asymptomatic cases to the development of mild to severe respiratory illness, and in some instances, chronic lingering disease and mortality. The underlying biological mechanisms driving this wide spectrum of pathogenicity among certain individuals and demographics remain elusive. Autoantibodies have emerged as potential contributors to the severity of COVID‐19. Although preliminary reports have suggested the induction of antibodies targeting Angiotensin‐Converting Enzyme II (ACE2) post‐infection, this assertion lacks confirmation in large‐scale studies. In this study, our objective is to comprehensively characterize and quantify the prevalence and expression levels of autoantibodies directed against ACE2 in a sizable cohort ( n = 464). Our findings reveal that ACE2‐reactive IgM antibodies are the most prevalent, with an overall seroprevalence of 18.8%, followed by IgG at 10.3% and IgA at 6.3%. Longitudinal analysis of individuals with multiple blood draws showed stable ACE2 IgG and IgA levels over time. Upon stratifying individuals based on molecular testing for SARS‐CoV‐2 or serological evidence of past infection, no significant differences were observed between groups. Functional assessment of ACE2 autoantibodies demonstrated that they are non‐neutralizing and failed to inhibit spike‐ACE2 interaction or affect the enzymatic activity of ACE2. Our results highlight that ACE2 autoantibodies are prevalent in the general population and were not induced by SARS‐CoV‐2 infection in our cohort. Notably, we found no substantiated evidence supporting a direct role for ACE2 autoantibodies in SARS‐CoV‐2 pathogenesis.
- 14 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (4) , e70390
Open AccessAutoantibodies targeting angiotensin‐converting enzyme 2 are prevalent and not induced by SARS ‐ CoV ‐2 infection
Clinical outcomes resulting from SARS‐CoV‐2 infection vary widely, ranging from asymptomatic cases to the development of mild to severe respiratory illness, and in some instances, chronic lingering disease and mortality. The underlying biological mechanisms driving this wide spectrum of pathogenicity among certain individuals and demographics remain elusive. Autoantibodies have emerged as potential contributors to the severity of COVID‐19. Although preliminary reports have suggested the induction of antibodies targeting Angiotensin‐Converting Enzyme II (ACE2) post‐infection, this assertion lacks confirmation in large‐scale studies. In this study, our objective is to comprehensively characterize and quantify the prevalence and expression levels of autoantibodies directed against ACE2 in a sizable cohort ( n = 464). Our findings reveal that ACE2‐reactive IgM antibodies are the most prevalent, with an overall seroprevalence of 18.8%, followed by IgG at 10.3% and IgA at 6.3%. Longitudinal analysis of individuals with multiple blood draws showed stable ACE2 IgG and IgA levels over time. Upon stratifying individuals based on molecular testing for SARS‐CoV‐2 or serological evidence of past infection, no significant differences were observed between groups. Functional assessment of ACE2 autoantibodies demonstrated that they are non‐neutralizing and failed to inhibit spike‐ACE2 interaction or affect the enzymatic activity of ACE2. Our results highlight that ACE2 autoantibodies are prevalent in the general population and were not induced by SARS‐CoV‐2 infection in our cohort. Notably, we found no substantiated evidence supporting a direct role for ACE2 autoantibodies in SARS‐CoV‐2 pathogenesis.
- Open Access
- 8 February 2025
- Published by Elsevier in EBioMedicine
- Vol. 113, 105592
The ongoing importance of patient-informed, collaborative research in advancing the definition and harmonization of post COVID-19 condition (PCC) subtypes across diverse populations
- 8 February 2025
- Published by Elsevier in EBioMedicine
- Vol. 113, 105592
Open AccessThe ongoing importance of patient-informed, collaborative research in advancing the definition and harmonization of post COVID-19 condition (PCC) subtypes across diverse populations
- Open Access
- 9 May 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1276391
Clinical and serological predictors of post COVID-19 condition–findings from a Canadian prospective cohort study
Introduction: More than 3 years into the pandemic, there is persisting uncertainty as to the etiology, biomarkers, and risk factors of Post COVID-19 Condition (PCC). Serological research data remain a largely untapped resource. Few studies have investigated the potential relationships between post-acute serology and PCC, while accounting for clinical covariates.Methods: We compared clinical and serological predictors among COVID-19 survivors with (n = 102 cases) and without (n = 122 controls) persistent symptoms ≥12 weeks post-infection. We selected four primary serological predictors (anti-nucleocapsid (N), anti-Spike, and anti-receptor binding domain (RBD) IgG titres, and neutralization efficiency), and specified clinical covariates a priori.Results: Similar proportions of PCC-cases (66.7%, n = 68) and infected-controls (71.3%, n = 87) tested positive for anti-N IgG. More cases tested positive for anti-Spike (94.1%, n = 96) and anti-RBD (95.1%, n = 97) IgG, as compared with controls (anti-Spike: 89.3%, n = 109; anti-RBD: 84.4%, n = 103). Similar trends were observed among unvaccinated participants. Effects of IgG titres on PCC status were non-significant in univariate and multivariate analyses. Adjusting for age and sex, PCC-cases were more likely to be efficient neutralizers (OR 2.2, 95% CI 1.11–4.49), and odds was further increased among cases to report deterioration in quality of life (OR 3.4, 95% CI 1.64–7.31). Clinical covariates found to be significantly related to PCC included obesity (OR 2.3, p = 0.02), number of months post COVID-19 (OR 1.1, p < 0.01), allergies (OR 1.8, p = 0.04), and need for medical support (OR 4.1, p < 0.01).Conclusion: Despite past COVID-19 infection, approximately one third of PCC-cases and infected-controls were seronegative for anti-N IgG. Findings suggest higher neutralization efficiency among cases as compared with controls, and that this relationship is stronger among cases with more severe PCC. Cases also required more medical support for COVID-19 symptoms, and described complex, ongoing health sequelae. More data from larger cohorts are needed to substantiate results, permit subgroup analyses of IgG titres, and explore for differences between clusters of PCC symptoms. Future assessment of IgG subtypes may also elucidate new findings.
- 9 May 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1276391
Open AccessClinical and serological predictors of post COVID-19 condition–findings from a Canadian prospective cohort study
Introduction: More than 3 years into the pandemic, there is persisting uncertainty as to the etiology, biomarkers, and risk factors of Post COVID-19 Condition (PCC). Serological research data remain a largely untapped resource. Few studies have investigated the potential relationships between post-acute serology and PCC, while accounting for clinical covariates.Methods: We compared clinical and serological predictors among COVID-19 survivors with (n = 102 cases) and without (n = 122 controls) persistent symptoms ≥12 weeks post-infection. We selected four primary serological predictors (anti-nucleocapsid (N), anti-Spike, and anti-receptor binding domain (RBD) IgG titres, and neutralization efficiency), and specified clinical covariates a priori.Results: Similar proportions of PCC-cases (66.7%, n = 68) and infected-controls (71.3%, n = 87) tested positive for anti-N IgG. More cases tested positive for anti-Spike (94.1%, n = 96) and anti-RBD (95.1%, n = 97) IgG, as compared with controls (anti-Spike: 89.3%, n = 109; anti-RBD: 84.4%, n = 103). Similar trends were observed among unvaccinated participants. Effects of IgG titres on PCC status were non-significant in univariate and multivariate analyses. Adjusting for age and sex, PCC-cases were more likely to be efficient neutralizers (OR 2.2, 95% CI 1.11–4.49), and odds was further increased among cases to report deterioration in quality of life (OR 3.4, 95% CI 1.64–7.31). Clinical covariates found to be significantly related to PCC included obesity (OR 2.3, p = 0.02), number of months post COVID-19 (OR 1.1, p < 0.01), allergies (OR 1.8, p = 0.04), and need for medical support (OR 4.1, p < 0.01).Conclusion: Despite past COVID-19 infection, approximately one third of PCC-cases and infected-controls were seronegative for anti-N IgG. Findings suggest higher neutralization efficiency among cases as compared with controls, and that this relationship is stronger among cases with more severe PCC. Cases also required more medical support for COVID-19 symptoms, and described complex, ongoing health sequelae. More data from larger cohorts are needed to substantiate results, permit subgroup analyses of IgG titres, and explore for differences between clusters of PCC symptoms. Future assessment of IgG subtypes may also elucidate new findings.
- Open Access
- 1 March 2024
- Published by American Psychological Association (APA) in Journal of Pediatric Neuropsychology
- Vol. 10 (1) , 49-90
The lost years: An integrative review of the mental health, educational, and social impact of the pandemic on children and adolescents from 2019 to 2022.
The COVID-19 pandemic has been extremely stressful worldwide, impacting just about every facet of life. Its impact on children has been the subject of much research since it started in 2019, particularly since the “lockdown” in March 2020. We are only beginning to understand the widespread ramifications of the lockdown and subsequent practices of social distancing and quarantining to prevent the spread of the virus on children, adolescents, and families. This study aimed to present an integrative review of the mental health, academic achievement, and social functioning of children and adolescents since the initial lockdown. While much of the research was focused on the acute phases of the pandemic, we are still left with a lesser understanding of the long-term implications. We reviewed 50 studies examining the impact on youth’s mental health, academic achievement, and social functioning, as well as the risk factors associated with poorer outcomes. We conclude that future research should adopt a broad conceptualization of the biopsychosocial, economic, and cultural impact of the pandemic on children and adolescents.
- 1 March 2024
- Published by American Psychological Association (APA) in Journal of Pediatric Neuropsychology
- Vol. 10 (1) , 49-90
Open AccessThe lost years: An integrative review of the mental health, educational, and social impact of the pandemic on children and adolescents from 2019 to 2022.
The COVID-19 pandemic has been extremely stressful worldwide, impacting just about every facet of life. Its impact on children has been the subject of much research since it started in 2019, particularly since the “lockdown” in March 2020. We are only beginning to understand the widespread ramifications of the lockdown and subsequent practices of social distancing and quarantining to prevent the spread of the virus on children, adolescents, and families. This study aimed to present an integrative review of the mental health, academic achievement, and social functioning of children and adolescents since the initial lockdown. While much of the research was focused on the acute phases of the pandemic, we are still left with a lesser understanding of the long-term implications. We reviewed 50 studies examining the impact on youth’s mental health, academic achievement, and social functioning, as well as the risk factors associated with poorer outcomes. We conclude that future research should adopt a broad conceptualization of the biopsychosocial, economic, and cultural impact of the pandemic on children and adolescents.